Insider · CIK 0001219016

BONNEY MICHAEL W

Reports to the SEC for 16 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001219016

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	AUTLAutolus Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+31.7K sh	—	—	31,667
2026-06-29	IMUXIMMUNIC, INC. · Stock OptionA Award	Director	AAward	+100K sh	—	—	100,000
2026-06-29	AUTLAutolus Therapeutics plc · Share Option (Right to Buy)A Award	Director	AAward	+47.5K sh	—	—	47,500
2025-08-18	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	0
2025-08-18	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	$70.20	+$790K	28,054
2025-08-18	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.3K sh	$450.00	−$5.06M	16,804
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−549 sh	$267.14	−$147K	27,505
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,239 sh	$278.01	−$344K	21,755
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−802 sh	$282.03	−$226K	20,149
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,728 sh	$282.81	−$489K	18,421
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	0
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−431 sh	$271.68	−$117K	26,100
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−660 sh	$273.16	−$180K	25,440
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	$131.21	+$1.48M	28,054
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−372 sh	$281.10	−$105K	20,951
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−882 sh	$273.75	−$241K	24,558
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−301 sh	$275.63	−$83K	24,257
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−432 sh	$280.03	−$121K	21,323
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,263 sh	$277.16	−$350K	22,994
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,617 sh	$283.83	−$459K	16,804
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−729 sh	$268.56	−$196K	26,776
2025-05-15	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−245 sh	$269.79	−$66.1K	26,531
2025-05-08	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+1,558 sh	—	—	1,558
2025-05-08	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director	AAward	+775 sh	—	—	16,804
2024-05-16	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,228 sh	—	—	5,228
2023-12-27	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−30K sh	$195.00	−$5.85M	16,029
2023-12-27	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2023-12-27	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$96.45	+$2.89M	46,029
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−560 sh	$183.75	−$103K	21,117
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$182.45	−$91.2K	21,677
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−300 sh	$181.08	−$54.3K	22,177
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−450 sh	$187.71	−$84.5K	16,029
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,389 sh	$187.04	−$260K	16,479
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,714 sh	$185.99	−$319K	17,868
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,535 sh	$184.89	−$284K	19,582
2023-08-02	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+22.5K sh	—	—	22,477
2023-08-02	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−22.5K sh	—	—	0
2023-05-18	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,454 sh	—	—	3,454
2021-08-02	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+22.5K sh	—	—	22,477
2021-07-15	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,032 sh	—	—	4,032
2021-06-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+345.331 sh	—	—	9,341.7
2021-06-30	Kaleido Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-13	BMYBRISTOL MYERS SQUIBB COM Exercise/Conversion	Director	MExercise/Conversion	+902 sh	—	—	12,501
2021-06-13	BMYBRISTOL MYERS SQUIBB CO · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−902 sh	—	—	0
2021-06-03	BMYBRISTOL MYERS SQUIBB COM Exercise/Conversion	Director	MExercise/Conversion	+2,949 sh	—	—	11,599
2021-06-03	BMYBRISTOL MYERS SQUIBB CO · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,949 sh	—	—	2,949
2021-06-01	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+18.2K sh	—	—	18,188
2021-03-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+365.516 sh	$63.13	+$23.1K	8,930.258
2021-02-01	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+3,054.171 sh	$62.21	+$190K	8,564.742
2020-12-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+371.997 sh	$62.03	+$23.1K	5,467.507

Recent filings

Accepted (ET)
Jul 14
BONNEY MICHAEL W0001730463-26-000091
SEC(opens sec.gov)
Jun 294
BONNEY MICHAEL W0001193805-26-000883
SEC(opens sec.gov)
Aug 194
BONNEY MICHAEL W0001735276-25-000087
SEC(opens sec.gov)
May 194
BONNEY MICHAEL W0001735276-25-000072
SEC(opens sec.gov)

Companies

Address

THE MEDIAWORKS, WHITE CITY C/O AUTOLUS THERAPEUTICS PLC

LONDON, W12 7FP